ADHD and Anxiety: Clinical Implications

Angold A. Costello E. J. Erkanli A. (1999). Comorbidity. Journal of Child Psychology and Psychiatry, 40, 57-87.

Bloch Y. Aviram S. Segev A. Nitzan U. Levkovitz Y. Braw Y. Mimouni Bloch A. (2017). Methylphenidate reduces state anxiety during a continuous performance test that distinguishes adult ADHD patients from controls. Journal of Attention Disorders, 21, 46-51.

Dan O. Raz S. (2015). The relationships among ADHD, self-esteem, and test anxiety in young adults. Journal of Attention Disorders, 19, 231-239.

Diamond I. R. Tannock R. Schachar R. J. (1999). Response to methylphenidate in children with ADHD and comorbid anxiety. Journal of the American Academy of Child and Adolescent Psychiatry, 38, 402-409.

Durell T. M. Adler L. A. Williams D. W. Deldar A. McGough J. J. Glaser P. E. . . . Fox B. K. (2013). Atomoxetine treatment of attention-deficit/hyperactivity disorder in young adults with assessment of functional outcomes: A randomized, double-blind, placebo-controlled clinical trial. Journal of Clinical Psychopharmacology, 33, 45-54.

Gabriel A. (2010). The mixed amphetamine salt extended release (Adderall XR, Max-XR) as an adjunctive to SSRIS or SNRIS in the treatment of adult ADHD patients with comorbid partially responsive generalized anxiety: An open-label study. Attention Deficit Hyperactivity Disorder, 2, 87-92. doi:10.1007/s12402-010-0025-z

Geller D. A. Donnelly C. Lopez F. Rubin R. Newcorn J. Sutton V. . . . Sumner C. (2007). Atomoxetine treatment for pediatric patients with attention-deficit/hyperactivity disorder with comorbid anxiety disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 46, 1119-1127.

Houghton S. Alsalmi N. Tan C. Taylor M. Durkin K. (2017). Treating comorbid anxiety in adolescents with ADHD using a cognitive behavior therapy program approach. Journal of Attention Disorders, 21, 1094-1104.

Hoza B. Pelham W. E. Milich R. Pillow D. McBride K. (1993). The self-perceptions and attributions of attention deficit hyperactivity disordered and nonreferred boys. Journal of Abnormal Child Psychology, 21, 271-286.

Jarrett M. A. Wolff J. C. Davis T. E. Cowart M. J. Ollendick T. H. (2016). Characteristics of children with ADHD and comorbid anxiety. Journal of Attention Disorders, 20, 636-644.

Kessler R. C. Adler L. Barkley R. Biederman J. Conners C. K. Demler O. . . .Zaslavsky A. M. (2006). The prevalence and correlates of adult ADHD in the United States: Results from the National Comorbidity Survey Replication. The American Journal of Psychiatry, 163, 716-723.

MTA Cooperative Group. (1999). Moderators and mediators of treatment response for children with attention-deficit/hyperactivity disorder: The Multimodal Treatment Study of children with attention-deficit/hyperactivity disorder. Archives of General Psychiatry, 56, 1088-1096.

Newcorn J. H. Halperin J. M. Jensen P. S. Abikoff H. B. Arnold L. E. Cantwell D. P. . . . Vitiello B. (2001). Symptom profiles in children with ADHD: Effects of comorbidity and gender. Journal of the American Academy of Child and Adolescent Psychiatry, 40, 137-146.

Pliszka S. R. (2009). Treating ADHD and comorbid disorders: Psychosocial and psychopharmacological interventions. New York, NY: Guilford Press.

Pliszka S. R. (2011). Anxiety disorders. In Goldstein S. Reynolds C. R. (Eds.), Handbook of neurodevelopmental and genetic disorders in children (2nd ed., pp. 188-208). New York, NY: Guilford Press.

Prevatt F. Dehili V. Taylor N. Marshall D. (2015). Anxiety in college students with ADHD: Relationship to cognitive functioning. Journal of Attention Disorders, 19, 222-230.

Reimherr F. W. Marchant B. K. Gift T. E. Steans T. A. (2017). ADHD and anxiety: Clinical significance and treatment implications. Current Psychiatry Reports, 19, 109.

Snircova E. Marcincakova-Husarova V. Hrtanek I. Kulhan T. Ondrejka I. Nosalova G. (2016). Anxiety reduction on atomoxetine and methylphenidate medication in children with ADHD. Pediatrics International, 58, 476-481.

Swanson J. Arnold L. E. Kraemer H. Hechtman L. Molina B. Hinshaw S. , . . . MTA Cooperative Group. (2008). Evidence, interpretation, and qualification from multiple reports of long-term outcomes in the Multimodal Treatment study of children with ADHD (MTA): Part I: Executive summary. Journal of Attention Disorders, 12, 4-14. doi:10.1177/1087054708319345

Tannock R. (2000). Attention deficit disorders with anxiety disorders. In Brown T. E. (Ed.), Attention-deficit disorders and comorbidities in children, adolescents and adults (pp. 125-175). New York, NY: American Psychiatric Press.

Tong L. Shi H. J. Zhang Z. Yuan Y. Xia Z. J. Jiang X. X. Xiong X. (2016). Mediating effect of anxiety and depression on the relationship between attention-deficit/hyperactivity disorder symptoms and smoking/drinking. Science Reports, 6, 21609.

Vance A. Costin J. Barnett R. Luk E. Maruff P. Tonge B. (2002). Characteristics of parent- and child-reported anxiety in psychostimulant medication naive, clinically referred children with Attention Deficit Hyperactivity Disorder, Combined Type (ADHD-CT). Australian and New Zealand Journal of Psychiatry, 36, 234-239.